E15-EXPODIET: Exposición alimentaria a contaminantes ambientales
Epidemiología y Salud Pública / IBS-E15
El grupo de Nutrición, Dieta y Evaluación de Riesgos se centra en la Investigación de la Exposición Alimentaria a Disruptores Endocrinos y su efecto en enfermedades metabólicas como la obesidad.
Líneas de investigación
- Estimación de la exposición a disruptores endocrinos en población europea
- Estudio del efecto de la exposición a disruptores endocrinos en diferentes enfermedades
- Estudio del efecto de la exposición a disruptores endocrinos en la microbiota
- Identificación de genes asociados a las enfermedades hormono-dependientes
Palabras clave
Disruptor endocrino, Exposición Alimentaria, Obesidad
INMACULADA MOSCOSO RUIZ
VIVIANA RAMIREZ LOPEZ
JORGE MORENO FERNANDEZ
SILVIA MARTINEZ DIZ
JAVIER DIAZ CASTRO
ANA LOPEZ MORENO
MARIA VEGA ALMAZAN FERNANDEZ DE BOBADILLA
RAQUEL AVILA VILLEGAS
MARIA JESUS ALVAREZ CUBERO
ALBERTO ZAFRA GOMEZ
YOLANDA GALVEZ ONTIVEROS
CELIA MONTEAGUDO SANCHEZ
ANA MARIA RIVAS VELASCO
The Role of Endocrine Disrupting Chemicals in Gestation and Pregnancy Outcomes
NUTRIENTS, 2023;
FI:5,9; Q1
Presence of Parabens in Different Children Biological Matrices and Its Relationship with Body Mass Index
NUTRIENTS, 2023;
FI:5,9; Q1
Levels of Bisphenol A and its analogs in nails, saliva, and urine of children: a case control study
FRONTIERS IN NUTRITION, 2023;
FI:5; Q2
Presence of parabens in children?s faeces. Optimization and validation of a new analytical method based on the use of ultrasound-assisted extraction and liquid chromatography-tandem mass spectrometry
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2023;
FI:3,4; Q2
Editorial: Risk of dietary hazardous substances and impact on human microbiota: possible role in several dysbiosis phenotypes, volume II
FRONTIERS IN MICROBIOLOGY, 2023;
FI:5,2; Q2
COVID-19 during Gestation: Maternal Implications of Evoked Oxidative Stress and Iron Metabolism Impairment.
ANTIOXIDANTS, 2022;
FI:7,675; D1
Genetic variants of antioxidant enzymes and environmental exposures as molecular biomarkers associated with the risk and aggressiveness of bladder cancer
SCIENCE OF THE TOTAL ENVIRONMENT, 2022;
FI:10,753; D1
Implications of Vitamins in COVID-19 Prevention and Treatment through Immunomodulatory and Anti-Oxidative Mechanisms
ANTIOXIDANTS, 2022;
FI:7,675; D1
Role of endocrine disrupting chemicals in children’s neurodevelopment
ENVIRONMENTAL RESEARCH, 2022;
FI:8,431; D1
Culturing and Molecular Approaches for Identifying Microbiota Taxa Impacting Children’s Obesogenic Phenotypes Related to Xenobiotic Dietary Exposure.
NUTRIENTS, 2022;
FI:6,706; Q1
Dietary exposure to parabens and body mass index in an adolescent Spanish population.
ENVIRONMENTAL RESEARCH, 2021;
FI:6,498; D1
Analytical methods for the determination of endocrine disrupting chemicals in cosmetics and personal care products: A review
TALANTA, 2021;
FI:6,057; Q1
Determination of ultraviolet filters in human nails using an acid sample digestion followed by ultra-high performance liquid chromatography-mass spectrometry analysis
CHEMOSPHERE, 2021;
FI:7,086; Q1
Antimicrobial Effects of Potential Probiotics of Bacillus spp. Isolated from Human Microbiota: In Vitro and In Silico Methods
MICROORGANISMS, 2021;
FI:4,128; Q2
Body composition, mineral metabolism, and endocrine function of adipose tissue: influence of a nutritional supplement of propolis
NUTRICION HOSPITALARIA, 2021;
FI:1,057; Q4
Assessing bioaccumulation potential of personal care, household and industrial products in a marine echinoderm (Holothuria tubulosa)
SCIENCE OF THE TOTAL ENVIRONMENT, 2020;
FI:6,551; D1
Common sea urchin (Paracentrotus lividus) and sea cucumber of the genus Holothuria as bioindicators of pollution in the study of chemical contaminants in aquatic media. A revision
ECOLOGICAL INDICATORS, 2020;
FI:4,229; Q1
Determination of endocrine disrupting chemicals in human nails using an alkaline digestion prior to ultra-high performance liquid chromatography-tandem mass spectrometry
TALANTA, 2020;
FI:5,339; Q1
Endobolome, a New Concept for Determining the Influence of Microbiota Disrupting Chemicals (MDC) in Relation to Specific Endocrine Pathogenesis
FRONTIERS IN MICROBIOLOGY, 2020;
FI:4,236; Q1
Endocrine Disruptors in Food: Impact on Gut Microbiota and Metabolic Diseases
NUTRIENTS, 2020;
FI:4,546; Q1
Bisphenol A Analogues in Food and Their Hormonal and Obesogenic Effects: A Review
NUTRIENTS, 2019;
FI:4,171; Q1
Effect of Light Exposure on the Quality and Phenol Content of Commercial Extra Virgin Olive Oil during 12-Month Storage
JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 2019;
FI:1,72; Q2
Adherence to Mediterranean diet and risk of prostate cancer
AGING MALE, 2019;
FI:2,5; Q2
Determination of bisphenols with estrogenic activity in plastic packaged baby food samples using solid-liquid extraction and clean-up with dispersive sorbents followed by gas chromatography tandem mass spectrometry analysis
TALANTA, 2018;
FI:4,244; Q1
Effect of olive oil phenolic compounds on osteoblast differentiation
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018;
FI:3,086; Q1
Effect of phenolic extracts from different extra-virgin olive oil varieties on osteoblast-like cells
PLOS ONE, 2018;
FI:2,766; Q1
Bioactive compounds of the Mediterranean diet and prostate cancer
AGING MALE, 2018;
FI:2,5; Q2
Beverage consumption patterns and energy contribution from beverages per meal type: results from a national dietary survey in Sweden
PUBLIC HEALTH NUTRITION, 2018;
FI:2,485; Q2
Chemosensory characterization of virgin olive oils obtained from organic and conventional practices during fruit ripening
FLAVOUR AND FRAGRANCE JOURNAL, 2017;
FI:1,644; Q2
Folate intake in a Swedish adult population: Food sources and predictive factors
FOOD & NUTRITION RESEARCH, 2017;
FI:2,039; Q2
Reported habitual intake of breakfast and selected foods in relation to overweight status among seven- to nine-year-old Swedish children
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2017;
FI:1,339; Q3
Association of bisphenol A exposure with dietary quality indices in Spanish schoolchildren
FOOD AND CHEMICAL TOXICOLOGY, 2016;
FI:3,584; D1
Comparison of Mediterranean diet compliance between European and non-European populations in the Mediterranean basin
APPETITE, 2016;
FI:3,125; Q1
Effects of maternal diet and environmental exposure to organochlorine pesticides on newborn weight in Southern Spain
CHEMOSPHERE, 2016;
FI:3,698; Q1
Phenolic Compounds in Extra Virgin Olive Oil Stimulate Human Osteoblastic Cell Proliferation
PLOS ONE, 2016;
FI:3,057; Q1
Proposal of a Mediterranean Diet Serving Score
PLOS ONE, 2015;
FI:3,234; Q1
Proposal of a Nutritional Quality Index (NQI) to Evaluate the Nutritional Supplementation of Sportspeople
PLOS ONE, 2015;
FI:3,234; Q1
Evaluation of antioxidant activity and nutritional composition of flavoured dehydrated soups packaged in different formats. Reducing the sodium content
JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE, 2015;
FI:2,203; Q1
Effect of Agronomical Practices on the Nutritional Quality of Virgin Olive Oil at Different Ripening Stages
JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 2015;
FI:1,541; Q2
Self-perception of body weight status in older Dutch adults
JOURNAL OF NUTRITION HEALTH & AGING, 2015;
FI:2,996; Q2
Fármacos y disruptores endocrinos en el medioambiente. Comportamiento y destino comocontaminantes
Financiador: UNIVERSIDAD DE GRANADA
Número de expediente: C-EXP-047-UGR23
Tiempo de ejecución: 01/01/2024 - 31/12/2026
IP: ALBERTO ZAFRA GOMEZ
Estudio de la exposición postnatal a disruptores endocrinos en obesidad y neurodesarrollo infantil
Financiador: UNIVERSIDAD DE GRANADA
Número de expediente: PPJIB2023-026
Tiempo de ejecución: 01/01/2024 - 31/12/2024
IP: VIVIANA RAMIREZ LOPEZ
Efecto de la exposición a disruptores endocrinos en la obesidad y neurodesarrollo. Papel de la variabilidad genética y la microbiota (NEUROBESS)
Financiador: INSTITUTO DE SALUD CARLOS III - FEDER
Número de expediente: PI23/01359
Tiempo de ejecución: 01/01/2024 - 31/12/2026
IP: ANA MARIA RIVAS VELASCO
Herramienta de ayuda a la decisión en la selección de tratamiento de pacientes de cáncer de próstata.
Financiador: INSTITUTO DE SALUD CARLOS III - FEDER
Número de expediente: PMPTA23/00025
Tiempo de ejecución: 01/01/2024 - 31/12/2025
IP: MARIA JESUS ALVAREZ CUBERO
EFECTO DE LA EXPOSICIÓN POSTNATAL A DISRUPTORES ENDOCRINOS EN LOS TRASTORNOS DEL NEURODESARROLLO Y LA OBESIDAD INFANTIL. PAPEL DE LA VARIABILIDAD GENÉTICA
Financiador: FUNDACIÓN PÚBLICA PARA LA INVESTIGACIÓN BIOSANITARIA DE ANDALUCIA ORIENTAL ALEJANDRO OTERO (FIBAO)
Número de expediente: INTRAIBS-2021-02
Tiempo de ejecución: 05/02/2022 - 04/02/2023
IP: MARIA VEGA ALMAZAN FERNANDEZ DE BOBADILLA
Caracterización profunda de la serie blanca de pacientes con patología COVID-19 para su cribado por agresividad.
Financiador: CONSEJERÍA DE SALUD Y FAMILIAS
Número de expediente: PECOVID-0006-2020
Tiempo de ejecución: 28/10/2021 - 27/10/2023
IP: SILVIA MARTINEZ DIZ
INFLUENCE OF ENDOCRINE DISRUPTERS CHEMICALS ON GUT MICROBIOTE: A MISSED LINK IN CHILDHOOD OBESITY (ENDOMICROMICS)
Financiador: INSTITUTO DE SALUD CARLOS III - FEDER
Número de expediente: PI20/01278
Tiempo de ejecución: 01/01/2021 - 31/12/2023
IP: ANA MARIA RIVAS VELASCO
ESTUDIO DE LA EXPOSICION A SUSTITUTOS DEL BESFENOS A DISCRUPTORES ENDOCRINOS EN NIÑOS EN EDAD ESCOLAR Y SU RELACION CON LA OBESIDAD
Financiador: FUNDACION MAPFRE
Número de expediente: MAPFRE2018
Tiempo de ejecución: 23/01/2019 - 22/01/2020
IP: ANA MARIA RIVAS VELASCO
Estudio de la exposición a analogos del Bisfenol A con actividad hormonal en niños en edad escolar y su relación con la obesidad.
Financiador: INSTITUTO DE SALUD CARLOS III - FEDER
Número de expediente: PI17/01758
Tiempo de ejecución: 01/01/2018 - 31/12/2020
IP: ANA MARIA RIVAS VELASCO
EFECTO DE LA EXPOSICIÓN ALIMENTARIA A DISRUPTORES ENDOCRINOS EN LA MICROBIOTA INTESTINAL EN NIÑOS. PAPEL EN EL FENOTIPO OBESOGENICO
Financiador: CONSEJERÍA DE SALUD Y FAMILIAS
Número de expediente: PE-0250-2019
Tiempo de ejecución: 23/12/2019 - 22/12/2023
IP: ANA MARIA RIVAS VELASCO
Estudio piloto multicéntrico, aleatorizado, doble-ciego de grupos paralelos para evaluar el efecto del consumo de una combinación de cepas probióticas y de una combinación de extractos de plantas y una cepa probiótica sobre la producción y la composición
Financiador: BIOSEARCH, S.A.
Tipo de prueba: INV. CLINICA PRODUCTO SANITARIO COM.
Tiempo de ejecución: 14/12/2020 - 28/02/2021
IP: MARIA VEGA ALMAZAN FERNANDEZ DE BOBADILLA